MNX1 and acute myeloid leukemia: Again, cells with MNX1 knockdown had a remarkable disadvantage over control cells, most prominently in spleen and peripheral blood (PB), indicating that MNX1 knockdown reduced in vivo growth of AML-661 cells (Fig. 7D).